Our Purpose

At Algae-C we strive to redesign the traditional approach of producing API’s. At the core of our research and technology platform is our desire to improve people’s wellbeing while having a positive impact on the planet and its natural ecosystems.

Algae pool

Overview

Algae-C is a biotechnology company headquartered in Ontario, Canada. Algae-C has perfected its plant-based API production platform working in collaboration with some of Canada’s top research institutions.

Today, Algae-C has brought together one of the largest algae biosynthetics teams from around the world, in addition to multiple key strategic partnerships to succeed in the market.

Our success is the result of valuable partnerships with Universities, research institutes, and industry partners across Canada.

Algae pool

Management Team

Dr. Mather Carscallen
CEO
Dr. Mather Carscallen
Ph.D. in Computational Biology and globally recognized for his work in the algae sector. Dr. Carscallen has over 15 years of experience scaling algae production in multiple countries and across numerous sectors, including biofuels, agriculture, and aquaculture.
Jocelyn Harris, CPA, CA
CFO
Over 15 years of strategic and operational experience in finance leadership. Former VP Finance for Canadian Ultra-Low Cost Flair Airlines. Deep experience in hyper-growth, cash-constrained environments.
Andrew Nichols
President
Andrew Nichols
Previously President/Chief Revenue Officer for BioSteel Sports Nutrition (acquired by Canopy Growth (TSX: WEED) and Managing Director of Crocs Canada where he reduced SG&A’s by 30%, and grew it to a $46M P&L.
Dave Matthews
COO
Dave Matthews
Over 35 years of experience constructing and operating ingredient production plants (16 plants worldwide). Created and operated production facility for Ocean Nutrition Canada ONC ($165M/yr. revenue) acquired by DSM (>$0.5B).
Alexandra Orozco, MBA
CMO
Alexandra Orozco
Over 15 years experience building and leading startups in life sciences with a focus on strategic marketing. Alexandra helped build Ascenta Health Ltd., which was acquired by Nature’s Way of Canada in 2015.
Flowing algae

Board of Advisors

Dr. Pere Paton
Pharmaceutical/APIs
Dr. Pere Paton
President of Global APIs at Apotex, Dr. Pere holds a PhD in Chemical Engineering and has over 20 years experience as a senior executive in the API business in a GMP environment.
Barry Fishman
Pharmaceuticals
Barry Fishman
Former CEO Teva Pharmaceuticals, Taro Canada, Merus Labs (TSX: MSL) and VIVO Cannabis (TSX: VIVO). M&A experience – IPO: Bedrocan, Mergers: Bedrocan and Tweed, Sales: Merus to Norgine, Acquisitions: Harvest Med. and Canna Farms.
Sharon James
Pharma/Strategy
Senior Advisor for Bain & company. Director for Novozyme (CPH: NZYM B) and Molnlycke Health Care. Former EVP of Global R&D for Bayer (NASDAQ: BAYRY). Former Senior VP of Global R&D for Reckitt Benckiser (LON: RKT).
Dr. Craig Behnke
Drug Discovery
EVP, Production and Development, Lumen Bioscience and Former VP, Business Development, Sapphire Energy. PhD in Biochemistry with over 16 years of experience in commercial biotechnology.
Leslie Ewing
Consumer Products
Executive Director, Plant-Based Foods of Canada. 25 years of managing multi-stakeholder projects with the consumer products industry liaising with Hershey, Nestle, Danone, Abbott, Greenleaf Foods, Beyond Meat and others.
Dave Shekhter
Business Development and Sales Strategy
Dave Shekhter
Over 15 years of business consulting, negotiations, and project management. Founded and exited Cannmart (acquired by Namaste Tech.) and Famous Brandz, among others.
Back to top